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Scaffold proteins have been established as important mediators of signal transduction specificity. The
insulin receptor substrate (IRS) proteins represent a critical group of scaffold proteins that are required for
signal transduction by the insulin receptor, including the activation of phosphatidylinositol 3 kinase. The c-Jun
NH2-terminal kinase (JNK)-interacting proteins (JIPs) represent a different group of scaffold molecules that
are implicated in the regulation of the JNK. These two signaling pathways are functionally linked because JNK
can phosphorylate IRS1 on the negative regulatory site Ser-307. Here we demonstrate the physical association
of these signaling pathways using a proteomic approach that identified insulin-regulated complexes of JIPs
together with IRS scaffold proteins. Studies using mice with JIP scaffold protein defects confirm that the JIP1
and JIP2 proteins are required for normal glucose homeostasis. Together, these observations demonstrate that
JIP proteins can influence insulin-stimulated signal transduction mediated by IRS proteins.
The c-Jun NH2-terminal kinase (JNK)-interacting proteins
(JIPs) are implicated in the regulation of the JNK signal trans-
duction pathway (8, 28). The JIP1 and JIP2 proteins are struc-
turally related with similar modular domains (SH3 and PTB)
and binding sites for the mixed-lineage protein kinase (MLK)
group of mitogen-activated protein kinase (MAPK) kinase ki-
nases, the MAPK kinase MKK7, and JNK (19). These JIP
proteins also interact with the microtubule motor protein ki-
nesin, several guanine nucleotide exchange factors, the phos-
phatase MKP7, Src-related protein kinases, and AKT to form
multifunctional protein complexes (19).
One potential physiological role of JIP scaffold proteins is
the response to metabolic stress, insulin resistance, and diabe-
tes. Several lines of evidence support this hypothesis. First,
JIP1 is required for metabolic stress-induced activation of JNK
in white adipose tissue (12). Second, MLKs that interact with
JIP proteins are implicated as essential components of a sig-
naling pathway that mediates the effects of metabolic stress on
JNK activation (13). Third, studies have demonstrated that the
human Jip1 gene may contribute to the development of type 2
diabetes, because a Jip1 missense mutation was found to seg-
regate with type 2 diabetes (26). Collectively, these data sug-
gest that JIP proteins play a role in the cellular response to
metabolic stress and the regulation of insulin resistance.
It is established that the insulin receptor substrate (IRS)
group of scaffold proteins plays a central role in insulin signal-
ing (27). Treatment of cells with insulin causes tyrosine phos-
phorylation of the insulin receptor, the recruitment of IRS
proteins to the insulin receptor, and the subsequent tyrosine
phosphorylation of IRS proteins on multiple residues that act
as docking sites for insulin-regulated signaling molecules, in-
cluding phosphatidylinositol 3 kinase (27). Negative regulation
of IRS proteins is implicated as a mechanism of insulin resis-
tance and can be mediated by multiple pathways, including
IRS protein phosphorylation and degradation. Thus, the
mTOR/p70S6K (21, 22, 24) and the SOCS-1/3 (20) signaling
pathways can regulate IRS protein degradation. Multisite
phosphorylation on Ser/Thr residues can also regulate IRS
protein function, including JNK phosphorylation of IRS1 on
the inhibitory site Ser-307 that prevents recruitment of IRS1 to
the activated insulin receptor (2).
The IRS and JIP groups of scaffold proteins may function
independently to regulate JNK-dependent and insulin-depen-
dent signal transduction. However, functional connections be-
tween these scaffold proteins have been identified. Thus, stud-
ies using Jip1/ mice demonstrate that JIP1 is required for
high-fat-diet-induced JNK activation in white adipose tissue,
IRS1 phosphorylation on the inhibitory site Ser-307, and insu-
lin resistance (12). These data suggest that JIP scaffold pro-
teins function cooperatively with IRS proteins to regulate sig-
nal transduction by the insulin receptor. The purpose of this
study was to examine cross talk between the JIP and IRS
scaffold complexes. We demonstrate that the JIP and IRS
scaffold complexes physically interact in an insulin-dependent
manner and confirm that JIP proteins influence normal glu-
cose homeostasis.
MATERIALS AND METHODS
Mice. The construction of Jip1/ mice (30) and Jip2/ mice (17) has been
described previously. Mice with a point mutation in JIP1 (Ser-59Asn) were
constructed by homologous recombination in embryonic stem (ES) cells using
standard methods. Briefly, a targeting vector was constructed (see Fig. 5A). This
targeting vector was designed to introduce point mutations in exon 2 of the Jip1
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gene that create the Ser59Asn mutation and also a novel AseI restriction site (see
Fig. 5B). TC1 ES cells (strain 129svev) were electroporated with this vector and
selected with 200 g/ml G418 (Invitrogen) and 2 M ganciclovir (Syntex). Cor-
rectly targeted ES cell clones were identified by using Southern blot analysis and
were injected into C57BL/6J blastocysts to create chimeric mice that were bred
to obtain germ line transmission of the mutated Jip1 allele. The floxed Neor
cassette was excised using Cre recombinase. The mice used in this study were
backcrossed (10 generations) to the C57BL/6J strain (Jackson Laboratories) and
were housed in a facility accredited by the American Association for Laboratory
Animal Care. The Institutional Animal Care and Use Committee of the Uni-
versity of Massachusetts approved all studies using animals.
Genotyping. Genomic DNA was examined using a PCR assay to detect the
wild-type and disrupted alleles of Jip1 or Jip2 (30). The Jip1S59N allele was
detected using two different assays. First, Southern blot analysis of AseI-re-
stricted genomic DNA was performed by probing with a 468-bp fragment of the
Jip1 gene that was isolated by PCR using the primers 5-GCTCAGTAAACAC
ACAAGGCTGGAG-3 and 5-CCCTGGAAGATGAAGACCTCAAAG-3.
The Jip1 and Jip1S59N alleles were detected as 11.9-kb and 4.9-kb bands, respec-
tively (see Fig. 5C). Second, a PCR assay was employed using the primers
5-ACGGAGGCATCTCTCCAATAGAGC-3, 5-TTCTGCCTCTATCCTTG
CTGGC-3, and 5-CAGGGTGTCTTTGCACTGCAGATTA-3. The Jip1 and
Jip1S59N alleles were amplified to yield 1,250- and 400-bp DNA fragments,
respectively (see Fig. 5D).
Plasmids. Mammalian expression vectors for IRS1 and IRS2 (provided by M.
White), Flag- and T7-tagged JIP1 (28), and Flag- and T7-tagged JIP2 (31) have
been described previously. Encoding epitope (EE)-tagged JIP1 and JIP2 were
created using an in-frame insertion of nucleotides that encode the EE (EYMPME)
between codons 1 and 2 of the JIP1 cDNA with a PCR-based approach. The
EE-JIP1 cDNA was subcloned as a blunt-end fragment into the BamHI site of
the retroviral vector pBABE-Puro.
Blood analysis. Insulin concentrations were measured using an enzyme-linked im-
munosorbent assay (ELISA) kit for rat insulin (Crystal Chem). Glucose levels were
measured using a blood glucose meter (Bayer Corporation, Mishawaka, IN). Adiponec-
tin, leptin, and resistin were measured by multiplexed ELISA using LINCOplex kits
(LINCO Research) assayed on a Luminex 200 instrument (LINCO Research).
Morphology. Histology was performed using tissue fixed in 10% formalin for
24 h, dehydrated, and embedded in paraffin. Sections (7 m) were cut and
stained using hematoxylin and eosin (American Master Tech Scientific). Immu-
nohistochemistry was performed by staining tissue sections with an antibody to
insulin (Dako), a biotinylated secondary antibody (BioGenex), streptavidin-con-
jugated horseradish peroxidase (BioGenex), and the substrate 3,3-diaminoben-
zidene (Vector Laboratories), followed by brief counterstaining with Mayer’s
hematoxylin (Sigma). Double staining for insulin and glucagon in islets was
performed using pancreatic tissue frozen in optimal cutting temperature com-
pound (Tissue-Tek). Tissue sections (12 m) were fixed in acetone, followed by
staining with antibodies to insulin (Dako) and glucagon (Zymed). The primary
antibodies were detected by incubation with anti-mouse or anti-rabbit immuno-
globulin conjugated to Alexa Fluor 488 or 633 (Molecular Probes). The fluores-
cence was visualized using a Leica TCS SP2 confocal microscope equipped with
a 405-nm diode laser. Analysis of fixed tissue by electron microscopy was per-
formed using ultrathin sections mounted on copper support grids that were
contrasted with lead citrate-uranyl acetate and examined on a Philips CM-10
transmission electron microscope at 80 kV accelerating voltage.
Tissue culture. Rin-5F, COS7, and 293T cells (American Type Culture Col-
lection) were cultured in RPMI 1640 medium with 2 mM L-glutamine modified
to contain 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/liter glucose, and 10%
fetal bovine serum (Rin-5F) or Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum (COS7 and 293T). Transient transfection
assays were performed using Lipofectamine (Invitrogen). Recombinant retrovi-
ruses were prepared by transfecting 293T cells with pBABE-Puro vectors and
-eco packaging DNA. Rin-5F cells were transduced with retroviruses and
selected by incubation in medium containing 2.5 g/ml puromycin.
Biochemical assays. Immunoblot analysis was performed using antibodies to
ankyrin G (provided by Steven Lambert, UMASS Medical School), ARP1
(Sigma), JIP1 and JIP2 (31), JIP3 (15), JIP4 (16), JNK1/2 (Pharmingen), phos-
pho-JNK (Cell Signaling), phosphotyrosine (Upstate), and -tubulin (Sigma).
FIG. 1. Proteomic analysis of JIP protein complexes. (A) The EE monoclonal antibody was used to prepare immunoprecipitates from Rin-5F
cells (Control) and from Rin-5F cells expressing EE-tagged JIP1. The immunoprecipitates were examined by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis. Silver-stained bands selectively present in JIP1 immunoprecipitates were excised and subjected to mass spectroscopy.
Sixteen different proteins were identified. Eight of these correspond to subunits of the proteasome (listed below the gel). The identities of an
additional eight proteins are annotated on the gel image. (B) Coimmunoprecipitation analysis of JIP1 complex formation. EE monoclonal antibody
immunoprecipitates were prepared from Rin-5F cells (Control) and Rin-5F cells expressing EE-tagged JIP1. These immunoprecipitates were
probed using antibodies to JIP proteins, JNK, ankyrin G, and ARP1. Immunoblot analysis of the cell lysate (100% of the amount used for the
coimmunoprecipitation) is also presented.
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JNK activity was measured in an in vitro kinase assay using c-Jun as the substrate
(29). Cell lysates were prepared using buffer containing 20 mM Tris-Cl, pH 8, 137
mM NaCl, 10% glycerol, and 0.2% Triton X-100. Immunoprecipitation assays
were performed by incubation of lysates with antibodies to the EE tag linked to
Sepharose (Covance), Flag tag (M2, Sigma), T7 tag (Novagen), IRS1 (provided
by M. White), or IRS 2 (Upstate). Coimmunoprecipitating proteins were de-
tected by immunoblot analysis or by mass spectroscopy using matrix-assisted
laser desorption ionization–quadrupole ion trap–time of flight tandem mass
spectrometry analysis (J. Lesyck, Proteomics Facility, University of Massachu-
setts Medical School).
RESULTS
Analysis of JIP1 scaffold complexes by mass spectroscopy.
We isolated JIP1 protein complexes from Rin-5F insulinoma
cells by immunoprecipitation (Fig. 1A). Sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis analysis indicated the
presence of a band corresponding to the expected electro-
phoretic mobility of JIP1 and a number of other proteins. To
identify these proteins, we performed mass spectroscopy using
matrix-assisted laser desorption ionization–quadrupole ion
FIG. 2. Interaction of IRS and JIP proteins. (A) Immunoprecipitates of endogenous IRS1 and IRS2 were prepared from Rin-5F cells (Control)
and Rin-5F cells expressing EE-tagged JIP1. These immunoprecipitates were probed using the EE monoclonal antibody and antibodies to IRS1
and IRS2. Immunoblot analysis of cell lysates (100% of the amount used for the coimmunoprecipitation) is also shown. (B) IRS proteins and T7
epitope-tagged JIP proteins were expressed in COS7 cells. The JIP proteins were immunoprecipitated using an antibody to the T7 epitope (IP).
The amount of IRS and JIP proteins in the cell lysate and the immunoprecipitates was examined by immunoblot analysis using antibodies to IRS1,
IRS2, and the T7 epitope tag on the JIP proteins. (C) Fragments of JIP1 with an NH2-terminal T7 epitope tag were coexpressed with IRS2 in COS7
cells. The amount of IRS2 in the cell lysate and in JIP1 (T7) immunoprecipitates (IP) was examined by immunoblot analysis using an antibody to
IRS2. The amount of JIP1 in the immunoprecipitates was examined by immunoblot analysis with a T7 monoclonal antibody. The heavy chain of
the immunoglobulin used for immunoprecipitation is present in every lane and is indicated by an asterisk. (D) Hemagglutinin-tagged IRS1 proteins
were coexpressed with T7-tagged JIP1 in COS7 cells. The effect of IRS1 mutations was examined, including the replacement of all 18 sites of Tyr
phosphorylation with Phe (F18), deletion of the PH domain (PH), deletion of the PTB domain (PTB), and deletion of portions of the
COOH-terminal region of IRS1 (PPY). JIP1 was immunoprecipitated using a T7 monoclonal antibody. The presence of IRS1 and JIP1 in the lysate
and immunoprecipitate was examined by immunoblot analysis.
FIG. 3. Interaction of endogenous JIP1 and IRS2. Rin-5F cells were
serum-starved (16 h) followed by treatment with 100 nM insulin (A) or
10% serum (B). Lysates were prepared from the cells at the indicated
times, and IRS2 was isolated by immunoprecipitation. The immunopre-
cipitates were examined by immunoblot analysis using antibodies to IRS2,
phosphotyrosine, and JIP1. The amount of IRS2, JIP1, and JNK in the
cell lysates was also examined by immunoblot analysis.
VOL. 29, 2009 IRS AND JIP SCAFFOLD COMPLEXES 4833
 o
n
 August 25, 2016 by UNIV O
F M
ASS M
ED SCH
http://m
cb.asm
.org/
D
ow
nloaded from
 
trap–time of flight tandem mass spectrometry analysis. These
studies led to the identification of JIP1 and 15 additional pro-
teins. Three of these proteins are molecular chaperones
(ERP1/GRP58, HSP70, and HSP90). The presence of chaper-
ones in JIP1 complexes was anticipated because similar mo-
lecular chaperones have been identified in other MAPK scaf-
fold complexes (19). Eight of the identified proteins correspond
to subunits of the proteasome (ATPase subunits 1, 5, and 6 and
non-ATPase subunits 3, 4, and 12) and two proteasome-asso-
ciated proteins (Adrm1 and Pad1 homolog). The presence of
these proteasome subunits is consistent with the finding that
JIP1 is degraded by the proteasome pathway (3).
Four additional proteins identified in JIP1 complexes by
mass spectroscopy were not anticipated. First, a subunit of the
dynactin complex (ARP1) that mediates interactions between
cargo molecules and the microtubule motor protein dynein was
identified (Fig. 1A). The presence of ARP1 in JIP1 complexes
was confirmed by coimmunoprecipitation-immunoblot analysis
(Fig. 1B). Previous studies have established that JIP1 interacts
with the light chain of the microtubule motor protein kinesin 1
(25, 30). Together, these findings suggest that JIP1 trafficking
on microtubules may be mediated by both kinesin and dynein
motor proteins. Second, the cytoskeletal protein ankyrin G was
identified in JIP1 complexes (Fig. 1A), and this was confirmed
by coimmunoprecipitation-immunoblot analysis (Fig. 1B).
Since ankyrin G is localized to the initial segment of axons and
is implicated in axonal protein recruitment (14), the interac-
tion of JIP1 with ankyrin G may account for the localization of
JIP1 in axonal projections during the early phase of neuronal
differentiation (7). Finally, two different scaffold proteins
(IRS2 and JIP4) were found in JIP1 immunoprecipitates (Fig.
1A). Coimmunoprecipitation analysis confirmed that JIP4 was
FIG. 4. The diabetes-associated polymorphism (Ser-59Asn) in JIP1 suppresses JNK activation. (A) Lysates were prepared from Rin-5F cells
expressing EE-tagged JIP1 or (S59N) JIP1. Lysates and JIP1 immunoprecipitates were probed by immunoblot analysis using antibodies to JIP1
and JNK. (B) Lysates were prepared from Rin-5F cells expressing EE-tagged JIP1 or (S59N) JIP1. Cell lysates and immunoprecipitates of
endogenous IRS2 were probed by immunoblot analysis using antibodies to IRS2 and JIP1. (C) Wild-type Rin-5F cells and Rin-5F cells expressing
EE-tagged JIP1 or (S59N) JIP1 were exposed to UV radiation (60 J/m2) and subsequently harvested at the indicated times. The amount of JIP1,
JNK, and phospho-JNK was examined by immunoblot analysis (IB). JNK activity was measured in an immunocomplex kinase assay (KA) using
[-32P]ATP and c-Jun as substrates. An autoradiograph showing the phosphorylated c-Jun is presented, and the amount of phospho-c-Jun was
quantitated by Phosphorimager analysis (mean 	 standard deviation; n 
 4). The JNK activity detected in cells expressing (S59N) JIP1 was
significantly reduced compared with that of cells expressing wild-type JIP1 (P  0.01).
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present in JIP1 complexes but also demonstrated the presence
of both JIP2 and JIP3 (Fig. 1B).
The JIP1 scaffold complex interacts with IRS proteins. Pro-
teomic analysis of JIP1 scaffold complexes led to the identifi-
cation of IRS2 (Fig. 1). To test the interaction of JIP1 with IRS
proteins, we immunoprecipitated endogenous IRS1 and IRS2
from lysates prepared from Rin5F cells and probed these im-
munoprecipitates for the presence of JIP1. This analysis dem-
onstrated that JIP1 coimmunoprecipitated with both IRS1 and
IRS2. Transfection assays confirmed the coimmunoprecipita-
tion of JIP1 with IRS1 and IRS2 (Fig. 2B) and also demon-
strated that the JIP1-related protein JIP2 coimmunoprecipi-
tated with IRS1 and IRS2 (Fig. 2B). Both JIP1 and the splice
variant JIP1b were able to interact with IRS2 (Fig. 2C). Dele-
tion analysis of JIP1b demonstrated that the NH2 terminus
(residues 1 to 281) and COOH terminus (residues 471 to 711)
did not interact with IRS2, but the central region of JIP1b
(residues 282 to 470) was sufficient for binding IRS2 (Fig. 2C).
Mutational analysis of IRS1 demonstrated that neither the PH
and PTB domains nor the 18 sites of Tyr phosphorylation of
FIG. 5. Creation of mice with the germ line point mutation Ser-59Asn in the Jip1 gene. (A to B) A targeting vector was designed to replace
Ser-59 with Asn and to introduce silent mutations that create an AseI site in exon II of the Jip1 gene by homologous recombination in ES cells.
The floxed Neor cassette used for selection was deleted using Cre recombinase. (C) Genomic DNA isolated from wild-type and mutant ES cells
was digested with AseI and examined by Southern blot analysis to confirm the correct targeting of the Jip1 gene. (D) Genomic DNA isolated from
wild-type (Jip1/), heterozygous (Jip1/S59N), and homozygous (Jip1S59N/S59N) mice was examined by PCR analysis. (E) Brain lysates from Jip1/
and Jip1S59N/S59N mice were examined by immunoblot analysis using antibodies to JIP1, JIP2, JIP3, JIP4, and -tubulin.
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IRS1 were required for the interaction of IRS1 with JIP1 (Fig.
2D). However, a truncated IRS1 protein (IRS1-PPY) was suf-
ficient for binding JIP1 (Fig. 2D).
Insulin regulates the interaction of JIP and IRS scaffold
proteins. Coimmunoprecipitation analysis demonstrated an in-
teraction between a fraction of the total JIP and IRS molecules
within the cell (Fig. 2). To test whether this interaction was
regulated by hormonal stimulation, we examined the effect of
treatment of cells with insulin on the coimmunoprecipitation
of JIP1 with IRS2 (Fig. 3). We found that the treatment of cells
with insulin caused no change in the expression of JIP1, IRS2,
or JNK1/2. However, when endogenous IRS2 was immunopre-
cipitated from lysates prepared from insulin-stimulated cells,
the amount of coimmunoprecipitated JIP1 was increased (Fig.
3A). Similar results were obtained when the cells were treated
with serum (Fig. 3B). These observations suggest that JIP/IRS
complexes may be dynamically regulated within cells.
Mutational analysis of JIP1 in vivo. JIP1 has been impli-
cated in type 2 diabetes because Jip1/ mice exhibit defects in
high-fat-diet-induced JNK activation and insulin resistance
(12). Furthermore, in studies of humans, a missense mutation
in the coding region of the Jip1 gene that replaces Ser-59 with
an Asn residue was found to segregate with type 2 diabetes,
demonstrating that the Jip1 gene may contribute to type 2
diabetes (26). This mutation may influence the function of
JIP1 (1, 3, 26). To test this hypothesis, we immunoprecipitated
wild-type and Ser-59Asn JIP1 from Rin5F insulinoma cells and
examined the amount of associated endogenous JNK and IRS2
by immunoblot analysis. This analysis demonstrated that the
Ser-59Asn mutation did not affect the binding of JIP1 to JNK
or IRS2 (Fig. 4A and B). Nevertheless, the Ser-59Asn muta-
tion did cause defects in JIP1 protein function. Thus, expres-
sion of wild-type JIP1, but not Ser-59Asn JIP1, was found to
cause increased stress-induced activation of JNK (Fig. 4C).
This effect of the Ser-59Asn mutation was detected when JNK
activation was monitored by in vitro protein kinase assays and
by immunoblot analysis using a phospho-JNK antibody
(Fig. 4C).
The segregation of the Ser-59Asn mutation with human type
2 diabetes (26) and the finding that this mutation alters the
biochemical properties of JIP1 (Fig. 4) suggested that the Ser-
59Asn JIP1 protein warranted further study. We therefore
created mice on the C57BL/6J strain background with a germ
line mutation in the Jip1 gene at codon 59 (Fig. 5A to D).
Heterozygous matings resulted in progeny with the expected
Mendelian ratios of wild-type, homozygous, and heterozygous
mice. The homozygous Jip1S59N/S59N mice were found to be
viable and fertile. Immunoblot analysis demonstrated that sim-
ilar amounts of JIP1 protein were detected in wild-type and
Jip1S59N/S59N mice (Fig. 5E). No compensatory changes in the
expression of JIP2, JIP3, or JIP4 were detected (Fig. 5E). To
test whether the Ser-59Asn mutation might alter the response
of mice being fed a high-fat diet, we examined cohorts of
littermate wild-type and Jip1S59N/S59N male mice fed either a
standard chow diet or a high-fat diet for 16 weeks. Both the
wild-type and mutant mice gained similar body mass and adi-
posity (data not shown) together with development of mild
fasting hyperglycemia (Fig. 6A) and hyperinsulinemia (Fig.
FIG. 6. Metabolic effect of the Jip1S59N mutation on the response to feeding a high-fat diet. Male Jip1/ (WT) and Jip1S59N/S59N (S59N) mice
were fed a standard chow diet (control) or a high-fat (HF) diet for 0, 6, or 16 weeks. (A to B) The mice were fasted overnight, and the plasma
concentrations of glucose (A) and insulin (B) were measured (mean 	 standard deviation [SD]; n 
 12). (C) The amount of plasma adiponectin,
resistin, and leptin after 16 weeks on the diet was measured by multiplexed ELISA assays (mean 	 SD; n 
 12). (D) The activity of JNK in
epididymal fat pads of the mice after 16 weeks on the control or HF diet was measured by using the immunocomplex kinase assay (KA) using
[-32P]ATP and c-Jun as the substrates. The amount of JNK and -tubulin in the cell lysate was examined by immunoblot analysis.
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6B). Similarly, no significant differences in glucose tolerance
and insulin tolerance tests (data not shown) and the blood
concentration of the adipokines adiponectin, resistin, and lep-
tin were detected between wild-type and Jip1S59N/S59N mice
(Fig. 6C). Nevertheless, feeding a high-fat diet caused a repro-
ducible, but modest, reduction in JNK activation in Jip1S59N/S59N
mice compared with wild-type mice (Fig. 6D). Thus, the Ser-
59Asn mutation in JIP1 causes marked changes in stress-in-
duced JNK activation in transfected cultured cells (Fig. 4), but
this mutation in the endogenous Jip1 gene caused only a small
change in obesity-induced JNK activation (Fig. 6D). The small
size of the decrease in JNK activation in vivo may account for
our failure to detect metabolic consequences of the Ser-59Asn
mutation in mice. Together, these data indicate that in a
C57BL/6J genetic background, the Ser-59Asn mutation in
JIP1, by itself, does not increase the susceptibility of mice to
diet-induced obesity and insulin resistance.
Redundant functions of JIP1 and JIP2. The absence of a
detected diabetes-related phenotype in Jip1S59N/S59N mice was
unexpected (Fig. 6). One explanation for this finding is that the
altered function of the Ser-59Asn JIP1 protein is compensated
by the expression of other JIP family proteins in mice. Indeed,
the JIP2 scaffold protein shares the same domain structure as
JIP1 (19). In contrast, the JIP3 and JIP4 scaffold proteins are
structurally distinct proteins (19). These considerations suggest
the possibility that there are functional redundancies between
the JIP1 and JIP2 scaffold proteins. Indeed, both JIP1 and JIP2
scaffold proteins form complexes with IRS1 and IRS2 (Fig.
2B). To test this hypothesis, we created compound mutant
mice that lack expression of both JIP1 and JIP2 (Fig. 7A to C).
The Jip1/ Jip2/ mice exhibited severe growth retardation
compared with littermate control mice and died within 2 weeks
after birth. This phenotype was not observed in studies of
Jip1S59N/S59N Jip2/ mice, consistent with the conclusion that
the Ser-59Asn JIP1 mutation causes only a partial loss JIP1
function. Interestingly, a comparison of Jip1/ Jip2/ mice
to littermate control mice demonstrated that the mutant mice
were hypoglycemic (Fig. 7D). It is possible that the ataxic
phenotype of Jip1/ Jip2/ mice (17) may disrupt feeding
behavior and therefore contribute to the hypoglycemia. Nev-
ertheless, our analysis indicates that JIP proteins in mice are
required for normal glucose homeostasis.
We have previously reported that JIP1-deficient mice exhibit
a major defect in IRS1 phosphorylation on Ser-307 in white
adipose tissue (12). White adipose tissue expresses JIP1, but
not JIP2. In contrast, brown adipose tissue expresses both JIP1
and JIP2. We therefore examined the effect of JIP1 deficiency
and JIP1/2 deficiency on IRS1 phosphorylation in brown fat
FIG. 7. Jip1/2 compound mutant mice exhibit severe growth retardation. (A and B) Littermate Jip1/ Jip2/ mice (left) and control (Jip1/
Jip2/) mice (right) at postnatal day 2 and day 10 are illustrated. (C) The body masses of littermate Jip1/ Jip2/ mice and control (Jip1/
Jip2/) mice at postnatal day 10 are presented (mean	 standard deviation [SD]; n
 6). The masses of the Jip1/ Jip2/ mice were significantly
less than those of the control mice. *, P  0.001. (D and E) Blood collected from wild-type and Jip1
/ Jip2/ mice was used to measure the
amount of glucose (D) and insulin (E). The data presented are the mean 	 SD (n 
 10). Significant differences between the Jip1/ Jip2/ mice
and control mice are indicated. *, P  0.01.
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tissue (Fig. 8). We found that JIP1 deficiency partially de-
creased, and that JIP1/2-deficiency blocked, insulin-stimulated
IRS1 Ser-307 phosphorylation. These data indicate that JIP1
and JIP2 can function cooperatively to induce IRS1 Ser-307
phosphorylation.
The JIP1 and JIP2 scaffold proteins have been reported to
be critical for the function and viability of pancreatic islets (5,
6, 9, 18). However, histological and immunocytochemical ex-
amination of pancreatic sections from Jip1/ Jip2/ mice
showed no obvious defect in islet morphology or in the levels
of insulin in  cells or glucagon in  cells (Fig. 9A to C). These
data demonstrate that, despite previous reports indicating an
important role of JIPs in insulin expression and -cell viability
(5, 6, 9, 18), the JIP1 and JIP2 proteins are not essential for
these processes. Nevertheless, detailed analysis of the pancreas
using electron microscopy did demonstrate that the  cells of
Jip1/ Jip2/ mice contained fewer exocytotic vesicles than
those of control mice (Fig. 9D). However, no significant dif-
ference in blood insulin concentration was detected between
control and Jip1/ Jip2/ mice (Fig. 7E).
DISCUSSION
The IRS and JIP scaffold proteins are implicated in the
regulation of the insulin and JNK signaling pathways, respec-
tively. Here we identify evidence of cross talk between these
two scaffold complexes. A proteomic mass spectroscopy ap-
proach and coimmunoprecipitation analysis demonstrated that
JIP1 and JIP2 protein complexes interact with IRS1 and IRS2
complexes (Fig. 1 and 2). Indeed, this interaction is increased
in cells treated with insulin (Fig. 3). The physiological signifi-
cance of this finding is most likely related to the role of JNK in
the regulation of insulin resistance (11) by mechanisms that
include the phosphorylation of IRS1 on the negative regula-
tory site Ser-307 (2).
During diet-induced obesity, JNK is activated by a signaling
pathway that is mediated by MLKs (13) that interact with JIP
scaffold proteins (12). Indeed, JIP scaffold proteins may assem-
ble a JNK signaling module composed of a MAPK kinase
kinase (one or more members of the MLK protein family), the
MAPK kinase MKK7, and JNK (28). Interestingly, high-fat-
diet-induced JNK activation in vivo is severely attenuated in
Mlk3/ and Jip1/ mice (12, 13). This requirement of JIP1
FIG. 8. Defects in the phosphorylation of IRS1 on Ser-307 in Jip1/2
compound mutant mice. Wild-type mice, Jip1/ mice, and Jip1/
Jip2/ mice (postnatal day 1) were treated without and with 1.5 U/kg
insulin by intraperitoneal injection. Extracts prepared from brown fat
were examined by immunoblot analysis using antibodies to IRS1 and
-tubulin. IRS1 immunoprecipitates prepared from the cell lysate were
probed with antibodies to IRS1 and phospho-Ser-307 IRS1. Densito-
metric analysis of immunoblots was employed to quantitate the effect
of insulin to increase the phosphorylation of IRS1 on Ser-307.
FIG. 9. Pancreatic morphology of Jip1/2 compound mutant mice.
(A to C) Sections of the pancreases from 7-day-old wild-type and
Jip1/ Jip2/ mice were stained with hematoxylin and eosin (A) or
with antibodies to insulin (B) or to insulin and glucagon (C). (D) The
morphology of pancreatic  cells was examined by using electron
microscopy.
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signaling complexes for high-fat-diet-induced JNK activation
provides an explanation for the finding that both Mlk3/ and
Jip1/ mice exhibit marked defects in the phosphorylation of
the IRS1 scaffold protein on the negative regulatory site Ser-
307 (12, 13). The interaction of JIP and IRS signaling com-
plexes suggests that JIP proteins may locally activate JNK and
also target JNK toward IRS protein phosphorylation.
The concept that scaffold molecules can increase signaling
specificity by locally activating specific signaling pathways is
well established (23). In addition, examples of substrate teth-
ering by scaffold proteins have been described previously, in-
cluding the interaction of AKAP scaffold proteins with gluta-
mate receptors (4). The interaction of IRS and JIP scaffold
complexes provides another example of localized signaling and
substrate targeting. A critical test of this hypothesis will be the
analysis of mice with a germ line mutation in the Jip1 or Jip2
gene that does not affect JIP-mediated JNK activation but does
disrupt the interaction of JIP1/2 with IRS1/2 proteins. The
creation of such mice represents an important goal for future
studies.
The link between JIP proteins and the insulin receptor sig-
naling pathway that we have identified is intriguing. The data
suggest that JIP proteins may influence insulin signaling in
disease. Indeed, it has been reported that the Ser-59Asn mu-
tation in the human Jip1 gene segregates with type 2 diabetes
(26), and JIP1 has been implicated as a protein that is critical
for the normal function of pancreatic islets, including insulin
gene expression and -cell viability (5, 6, 9, 18). Furthermore,
biochemical analysis demonstrated that the Ser-59Asn muta-
tion has a profound effect on JIP1 protein function, including
an altered ability to activate JNK (Fig. 4C). These data strongly
implicate the mutated human Jip1 allele in disease. To test this
hypothesis, we generated mice with a germ line mutation in the
Jip1 gene that encodes Asn rather than Ser at codon 59. We
found that this mutation did not predispose C57BL/6J mice to
type 2 diabetes when they were fed either chow or a high-fat
diet (Fig. 6). Our failure to detect a diabetes-related phenotype
in Ser-59Asn JIP1 mice may represent a difference between
mouse and human physiology. However, it may be significant
that a large fraction of the diabetic patients with the mutant
Jip1 allele were also carriers of a Pdx1 (Ipf1) mutation (26) that
has been previously associated with a late-onset form of dia-
betes (10). Thus, the Ser-59Asn Jip1 mutation in humans may
be particularly important in diabetes pathogenesis in patients
with increased diabetes susceptibility, including Pdx1 (Ipf1)
mutations.
Although the Ser-59Asn mutation in JIP1 may not be suffi-
cient, by itself, to cause obvious disease, it is likely that JIP1
proteins contribute to some aspects of metabolic syndrome.
Indeed, JIP1-deficent mice exhibit marked defects in obesity-
induced activation of the JNK signaling pathway (12). Since
the structurally related protein JIP2 also interacts with IRS
proteins (Fig. 2), it was possible that the JIP1 and JIP2 proteins
may have partially redundant functions. Indeed, we found that
the JIP1/2-deficient mice exhibited a severe growth retardation
phenotype, hypoglycemia, and early death (Fig. 7). This phe-
notype was not observed in Jip1/ mice (30) or Jip2/ mice
(17). These data confirm that the JIP1 and JIP2 proteins do
exhibit partially redundant functions and that these JIP pro-
teins are essential for normal glucose homeostasis.
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